Clinical Trials Browser

NETWORK × Recurrent Uterine Corpus Carcinoma × Granulocyte Colony-Stimulating Factor × Clear all

NCT00063999 2021-10-19

Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer

Phase 3 Completed

1,381 enrolled 12 charts

Recurrent Uterine Corpus Carcinoma